AB Science S.A.
EPA:AB.PA
0.938 (EUR) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.97 | 0.958 | 1.607 | 1.583 | 1.571 | 1.701 | 1.739 | 1.508 | 2.284 | 2.099 | 1.933 | 1.34 | 1.104 | 0.917 | 0.316 |
| Cost of Revenue
| 0.383 | 0.031 | 0.111 | 0.069 | 0.181 | 0.248 | 0.121 | 0.453 | 0.339 | 0.394 | 0.331 | 0.238 | 0.301 | 0.377 | 0.15 |
| Gross Profit
| 0.587 | 0.927 | 1.496 | 1.514 | 1.39 | 1.453 | 1.618 | 1.055 | 1.945 | 1.705 | 1.602 | 1.102 | 0.803 | 0.54 | 0.166 |
| Gross Profit Ratio
| 0.605 | 0.968 | 0.931 | 0.956 | 0.885 | 0.854 | 0.93 | 0.7 | 0.852 | 0.812 | 0.829 | 0.822 | 0.727 | 0.589 | 0.525 |
| Reseach & Development Expenses
| 10.477 | 13.345 | 11.233 | 12.841 | 15.583 | 26.926 | 26.734 | 27.856 | 23.711 | 13.366 | 12.118 | 8.725 | 7.586 | 7.994 | 5.833 |
| General & Administrative Expenses
| 1.485 | 1.867 | 3.578 | 2.641 | 2.263 | 2.388 | 2.269 | 2.477 | 2.316 | 2.03 | 1.83 | 1.909 | 1.843 | 10.515 | 12.264 |
| Selling & Marketing Expenses
| 0.355 | 0.288 | 0.493 | 0.781 | 1.018 | 1.082 | 1.019 | 0.928 | 1.882 | 1.512 | 1.425 | 1.08 | 1.091 | 1.461 | 0.988 |
| SG&A
| 3.539 | 2.155 | 4.071 | 3.422 | 3.281 | 3.47 | 3.288 | 3.405 | 4.198 | 3.542 | 3.255 | 2.989 | 2.934 | 11.976 | 13.252 |
| Other Expenses
| 1.699 | 1.365 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.001 | -5.833 |
| Operating Expenses
| 14.016 | 16.865 | 15.304 | 16.263 | 18.864 | 30.396 | 30.022 | 31.261 | 27.909 | 16.908 | 15.373 | 11.714 | 10.52 | 11.713 | 13.252 |
| Operating Income
| -13.429 | -15.938 | -13.808 | -14.749 | -17.474 | -28.944 | -28.404 | -30.207 | -25.964 | -15.203 | -13.772 | -10.613 | -9.716 | -9.589 | -8.297 |
| Operating Income Ratio
| -13.844 | -16.637 | -8.592 | -9.317 | -11.123 | -17.016 | -16.334 | -20.031 | -11.368 | -7.243 | -7.125 | -7.92 | -8.801 | -10.457 | -26.256 |
| Total Other Income Expenses Net
| 13.429 | 2.327 | -0.619 | -0.288 | -4.27 | 2.886 | 1.289 | 2.5 | -0.841 | -0.978 | -0.887 | -0.412 | 0.052 | 1.686 | 4.982 |
| Income Before Tax
| -10.047 | -13.611 | -14.427 | -15.037 | -21.744 | -26.057 | -27.115 | -27.706 | -26.805 | -16.181 | -14.658 | -11.024 | -9.665 | -9.487 | -8.104 |
| Income Before Tax Ratio
| -10.358 | -14.208 | -8.978 | -9.499 | -13.841 | -15.319 | -15.592 | -18.373 | -11.736 | -7.709 | -7.583 | -8.227 | -8.755 | -10.346 | -25.646 |
| Income Tax Expense
| 10.048 | 0.004 | 0.036 | 0.008 | 0.004 | 0.004 | 0.006 | -0.011 | -0.088 | -0.07 | -0.048 | -0.039 | -0.015 | 0.002 | 0.006 |
| Net Income
| -10.048 | -13.615 | -14.463 | -15.045 | -21.748 | -26.061 | -27.122 | -27.696 | -26.716 | -16.112 | -14.611 | -10.985 | -9.651 | -9.489 | -8.11 |
| Net Income Ratio
| -10.359 | -14.212 | -9 | -9.504 | -13.843 | -15.321 | -15.596 | -18.366 | -11.697 | -7.676 | -7.559 | -8.198 | -8.742 | -10.348 | -25.665 |
| EPS
| -0.2 | -0.29 | -0.3 | -0.34 | -0.55 | -0.69 | -0.75 | -0.78 | -0.78 | -0.49 | -0.45 | -0.34 | -0.31 | -0.32 | -0.28 |
| EPS Diluted
| -0.15 | -0.29 | -0.3 | -0.34 | -0.55 | -0.69 | -0.75 | -0.78 | -0.78 | -0.49 | -0.45 | -0.34 | -0.31 | -0.32 | -0.28 |
| EBITDA
| -5.466 | -11.595 | -11.411 | -13.773 | -20.653 | -25.134 | -26.777 | -26.251 | -25.522 | -14.924 | -12.934 | -9.966 | -9.239 | -8.693 | -7.611 |
| EBITDA Ratio
| -5.635 | -12.103 | -7.101 | -8.701 | -13.146 | -14.776 | -15.398 | -17.408 | -11.174 | -7.11 | -6.691 | -7.437 | -8.369 | -9.48 | -24.085 |